Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
2 clinical trials · Condition
◉ Watch Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer (NCT00390325) | National Cancer Institute (NCI) | 2006-11-03 |
| Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery (NCT00381641) | National Cancer Institute (NCI) | 2006-08-29 |
Track Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.